About methoxy polyethyl ene
Long-acting erythropoiesis-stimulating agent
Used for
- Treats anemia caused by chronic kidney disease in adults and children on dialysis.
- Treats anemia caused by chronic kidney disease in adults not on dialysis.
Usual adult dose
Usually given under the skin or into a vein every 2–4 weeks; dose is individualized using hemoglobin levels and prior treatment.
Usual dose in children
For children on dialysis, usually every 4 weeks; dose depends on body weight and prior anemia treatment.
Common side effects
- High blood pressure
- Diarrhea
- Headache
- Blood clots
Important warnings
- May increase the risk of death, heart attack, stroke, and blood clots when hemoglobin is raised too high.
- Not for anemia caused by cancer chemotherapy or for immediate correction of severe anemia.
- Blood pressure and hemoglobin require regular monitoring.
- Use the lowest dose needed to reduce blood transfusions.
Pregnancy
Human pregnancy information is limited; use only when the expected benefit outweighs potential risk.
Breastfeeding
It is unknown whether this medicine passes into breast milk; use caution during breastfeeding.
Interactions
- Other erythropoiesis-stimulating medicines can increase risks and should not be used together.
- Blood pressure medicines may need adjustment if blood pressure changes.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.